1-(3-beta-Azido-2,3-dideoxy-5-O-trityl-beta-D-threopenta-furanosyl)thyMine
Modify Date: 2024-02-11 13:51:03
1-(3-beta-Azido-2,3-dideoxy-5-O-trityl-beta-D-threopenta-furanosyl)thyMine structure
|
Common Name | 1-(3-beta-Azido-2,3-dideoxy-5-O-trityl-beta-D-threopenta-furanosyl)thyMine | ||
|---|---|---|---|---|
| CAS Number | 66503-47-7 | Molecular Weight | 509.56 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H27N5O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 1-(3-beta-Azido-2,3-dideoxy-5-O-trityl-beta-D-threopenta-furanosyl)thyMine1-(3-β-Azido-2,3-dideoxy-5-O-trityl-D-threopenta-furanosyl)thymine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1-[3'-azido-2',3'-dideoxy-5'-(triphenylmethyl)-β-D-threo-pentofuranosyl]-5-methylpyrimidine-2,4(1H,3H)-dione |
|---|---|
| Synonym | More Synonyms |
| Description | 1-(3-β-Azido-2,3-dideoxy-5-O-trityl-D-threopenta-furanosyl)thymine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C29H27N5O4 |
|---|---|
| Molecular Weight | 509.56 |
| Exact Mass | 509.20600 |
| PSA | 123.07000 |
| LogP | 4.27286 |
| Precursor 0 | |
|---|---|
| DownStream 1 | |
![1-[(2R,4R,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione structure](https://image.chemsrc.com/caspic/040/73971-82-1.png)
CAS#:73971-82-1| 1-(3-Azido-2,3-dideoxy-5-O-trityl-β-D-threo-pentofuranosyl)thymine |
| 1-(3'-azido-2',3'-dideoxy-5'-O-trityl-β-D-xylofuranosyl)thymine |
| 1-(3-azido-O5-trityl-β-D-threo-2,3-dideoxy-pentofuranosyl)-5-methyl-1H-pyrimidine-2,4-dione |